Stockscreener 앱 받기
14.40
0.04%
0.15
Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스
Real time scanner hits for Oruka Therapeutics Inc. explainedPortfolio Positioning Strategy With Timing - Newser
Technical analysis overview for Oruka Therapeutics Inc. stockShort Term Opportunity Finder with Tools - Newser
What makes Oruka Therapeutics Inc. stock price move sharplyAchieve rapid returns with smart investment plans - jammulinksnews.com
What are the latest earnings results for Oruka Therapeutics Inc.High-octane financial growth - jammulinksnews.com
What is Oruka Therapeutics Inc. company’s growth strategyGrow your wealth steadily and securely - jammulinksnews.com
How does Oruka Therapeutics Inc. compare to its industry peersSky-high return potential - jammulinksnews.com
Is it the right time to buy Oruka Therapeutics Inc. stockDiscover undervalued stocks before they soar - jammulinksnews.com
Is Oruka Therapeutics Inc. a growth stock or a value stockInvest smarter with daily market updates - jammulinksnews.com
What catalysts could drive Oruka Therapeutics Inc. stock higher in 2025Maximize gains with timely market signals - jammulinksnews.com
What is the risk reward ratio of investing in Oruka Therapeutics Inc. stockStay ahead with advanced stock screening tools - jammulinksnews.com
What institutional investors are buying Oruka Therapeutics Inc. stockAchieve breakthrough performance in the market - jammulinksnews.com
How high can Oruka Therapeutics Inc. stock price go in 2025Free Stock Market Strategy Classes - Newser
How volatile is Oruka Therapeutics Inc. stock compared to the marketDouble-digit growth - jammulinksnews.com
Why Oruka Therapeutics Inc. stock attracts strong analyst attentionFree Investment Risk Control - Newser
What analysts say about Oruka Therapeutics Inc. stockBreakthrough financial growth - PrintWeekIndia
What drives Oruka Therapeutics Inc. stock priceLightning-fast capital gains - Autocar Professional
Is Oruka Therapeutics Inc. a good long term investmentTremendous financial leverage - PrintWeekIndia
printweek> 2025> Oruka Therapeutics Inc. Stock Analysis and ForecastBreakthrough profits - PrintWeekIndia
H.C. Wainwright reiterates Buy rating on Oruka Therapeutics stock as FDA clears IND - Investing.com Canada
Oruka Therapeutics: Promising Pipeline and Strategic Advancements Drive Buy Rating - TipRanks
Strong Buy Recommendation for Oruka Therapeutics: Promising Pipeline and Attractive Valuation - TipRanks
Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN
Oruka Therapeutics Inc. Stock Analysis and ForecastMassive profits - Autocar Professional
Wedbush Reiterates Outperform Rating for Oruka Therapeutics (NASDAQ:ORKA) - Defense World
Oruka Therapeutics Announces IND Clearance for EVERLAST-A - GlobeNewswire
Oruka Therapeutics stock rises after FDA clears IND for psoriasis drug - Investing.com India
Stifel reiterates Buy rating on Oruka Therapeutics stock with $47 target - Investing.com Canada
Oruka Therapeutics: Revolutionizing Psoriasis Treatment with Extended-Dosing Biologics - AInvest
FDA clears Oruka’s IND for psoriasis drug ORKA-001 phase 2a trial - Investing.com
Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September - Yahoo Finance
0.47%
0.71%
자본화:
|
볼륨(24시간):